Advertisement
Screener

Alpha Compute Corp (ALP) Form 6-K: Report of foreign private issuer, 2014

Alpha Compute Corp Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2014-12-18: Form 6-K; Period of report 2014-12-18; Description BIOHAVEN UPDATE; Document pr121814.htm.
  • 2014-12-16: Form 6-K; Period of report 2014-12-16; Description PPL UPDATE; Document pr121614.htm.
  • 2014-11-28: Form 6-K; Period of report 2014-11-26; Description PORTAGEFINANCIALS2Q15; Document financialssept14.htm.
  • 2014-10-16: Form 6-K; Period of report 2014-10-16; Description CLOSURE OF PRIVATE PLACEMENT; Document pr101614.htm.
FiledFormPeriod of reportDescriptionDocument
2014-12-186-K2014-12-18BIOHAVEN UPDATEpr121814.htm
2014-12-166-K2014-12-16PPL UPDATEpr121614.htm
2014-11-286-K2014-11-26PORTAGEFINANCIALS2Q15financialssept14.htm
2014-10-166-K2014-10-16CLOSURE OF PRIVATE PLACEMENTpr101614.htm
2014-10-086-K2014-10-08APPOINTMENT OF ADDITIONAL CONSULTANTSpr10614.htm
2014-09-296-K2014-09-29CONVERSION OF DEBTS INTO EQUITYpr92914.htm
2014-09-246-K2014-09-24PORTAGE APPOINTS NEW CONSULTANTSpr92314.htm
2014-08-136-K2014-08-13QUARTERLY FINANCIALSpquarterlyfinancials.htm
2014-08-066-K2014-08-06BIOHAVEN PATENT APPROVALprbh.htm
2014-07-146-K2014-07-14SUCCESSFUL VALIDATION OF PEPTIDE PLATFORM TECHNOLOGYpr71414.htm
2014-05-166-K2014-05-15PORTAGE SIGNS A COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH US NATIONApr051514.htm
2014-05-086-K2014-05-08Report of foreign private issuerpr05082014.htm
2014-05-056-K2014-05-05PORTAGE?S BIOHAVEN ISSUED NOTICE OF ALLOWANCE: GLUTAMATE AGENTS IN THE TREATMENTpr050514.htm
2014-04-116-K2014-04-10PORTAGE PROVIDES UPDATESpr04102014.htm
2014-02-256-K2014-02-25PORTAGE REPORTS THIRD QUARTER FINANCIAL RESULTSpr02252014.htm
2014-02-256-K2013-12-31PORTAGE BIOTECH INC. THREE AND NINE MONTHS ENDED DECEMBER 31, 2013fsmda3q14.htm
2014-02-116-K2014-02-11FORM 6-K COVER SHEETcoversheet_asm2013.htm
2014-01-076-K2014-01-07PORTAGE ACQUIRES MAJORITY INTEREST IN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LIpr01062014.htm